Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide in patients with chronic hepatitis B: More questions than an answer
- Author:
Pin-Nan CHENG
1
;
Ming-Lung YU
Author Information
- Publication Type:Editorial
- From:Clinical and Molecular Hepatology 2024;30(2):144-146
- CountryRepublic of Korea
- Language:EN
